AVITA Medical, Inc.
  • About
    • About Overview
    • Leadership
    • Corporate Giving
    • Contact
  • Products
    • RECELL
      • RECELL GO
    • PermeaDerm
    • Cohealyx
    • Instructions for Use
  • Clinical Development
    • Pipeline/Clinical Trials
    • Patient Outcomes
    • Clinical Evidence
  • News & Media
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • News & Media
    • Financials
    • Annual Reports & Proxy
    • Stock Information
    • Corporate Governance
    • FAQ
    • Email Alerts
    • Contact
  • Careers
Select Page

AVITA Medical, Inc. First Quarter 2023 Earnings Conference Call

by Jaret Wilson | Jul 29, 2023 | Events

AVITA Medical to Announce Second Quarter 2023 Financial Results

by Jaret Wilson | Jul 20, 2023 | AVITA News, Press Releases

AVITA Medical Submits FDA PMA Supplement for RECELL GO

by Jaret Wilson | Jun 29, 2023 | AVITA News, Press Releases

AVITA Medical Rejoins the Russell 3000 Index

by Jaret Wilson | Jun 26, 2023 | AVITA News, Press Releases

Investor Webinar Briefing – First Quarter 2023

by Jaret Wilson | May 16, 2023 | Events

Next Entries »
  • Facebook
  • Twitter
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress